Plain-English translation of NCT07029256 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying whether ultrasound-guided core needle biopsy—a technique using sound waves to guide a needle into tissue—can accurately determine the stage of bladder cancer. Currently, staging usually requires surgical removal of the bladder. This study tests whether the needle biopsy method could work as an alternative or additional tool to help doctors understand how advanced the cancer is.
Staging bladder cancer accurately is critical for treatment planning, but current methods require major surgery. This research aims to see if a less invasive needle biopsy technique could provide the same staging information, potentially offering patients a gentler alternative.
You likely qualify if…
You likely don't qualify if…
If you qualify, you will undergo your planned bladder removal surgery as scheduled. During or after that surgery, doctors will perform the ultrasound-guided needle biopsy on tissue samples and collect data for the study. Researchers will also review your medical records to track outcomes. The study does not add extra procedures beyond what you're already having done for your cancer treatment.
AI-generated summary from trial data · Jun 15, 2026 · Not medical advice
United States
Enrollment target
~100 participants
Started
July 2024
Primary completion
July 2030
Age range
18 Years and older
Last updated on clinicaltrials.gov in June 2026.
Reach out to the team running this trial. Response times vary — some teams are faster than others.
Central contact
Hosanna Yeadon, BA
Mayo Clinic in Rochester
Tell us you're interested and we'll help connect you with the research team. We'll walk you through what to expect first — no email needed to get started.